×
Longer Time to Antipsychotic Treatment Discontinuation for Any Cause Is Associated With Better Functional Outcomes for Patients With Schizophrenia, Schizophreniform Disorder, or Schizoaffective Disorder PDF
$ 40.00
Longer Time to Antipsychotic Treatment Discontinuation for Any Cause Is Associated With Better Functional Outcomes for Patients With Schizophrenia, Schizophreniform Disorder, or Schizoaffective Disorder PDF quantity
$ 40.00
×
A High-Density Whole-Genome Association Study Reveals That APOE Is the Major Susceptibility Gene for Sporadic Late-Onset Alzheimer's Disease PDF
$ 40.00
A High-Density Whole-Genome Association Study Reveals That APOE Is the Major Susceptibility Gene for Sporadic Late-Onset Alzheimer's Disease PDF quantity
$ 40.00
×
Use of Non-Psychiatric Medications With Potential Depressive Symptom Side Effects and Level of Depressive Symptoms in Major Depressive Disorder PDF
$ 40.00
Use of Non-Psychiatric Medications With Potential Depressive Symptom Side Effects and Level of Depressive Symptoms in Major Depressive Disorder PDF quantity
$ 40.00
×
Risperidone Liquid Concentrate and Oral Lorazepam Versus Intramuscular Haloperidol and Intramuscular Lorazepam for Treatment of Psychotic Agitation PDF
$ 40.00
Risperidone Liquid Concentrate and Oral Lorazepam Versus Intramuscular Haloperidol and Intramuscular Lorazepam for Treatment of Psychotic Agitation PDF quantity
$ 40.00
×
Cytochrome P450 2D6 Polymorphism and Its Impact on Decision-Making in Psychopharmacotherapy: Finding the Right Way in an Ultrarapid Metabolizing Patient PDF
$ 40.00
Cytochrome P450 2D6 Polymorphism and Its Impact on Decision-Making in Psychopharmacotherapy: Finding the Right Way in an Ultrarapid Metabolizing Patient PDF quantity
$ 40.00
×
Safety of Selegiline Transdermal System in Clinical Practice: Analysis of Adverse Events From Postmarketing Exposures PDF
$ 40.00
Safety of Selegiline Transdermal System in Clinical Practice: Analysis of Adverse Events From Postmarketing Exposures PDF quantity
$ 40.00
×
Childhood Abuse and Platelet Tritiated-Paroxetine Binding in Bulimia Nervosa: Implications of Borderline Personality Disorder PDF
$ 40.00
Childhood Abuse and Platelet Tritiated-Paroxetine Binding in Bulimia Nervosa: Implications of Borderline Personality Disorder PDF quantity
$ 40.00
×
Use of Preventive Health Services in People With Serious Mental Illness: Consumer Perspectives on Barriers and Solutions PDF
$ 40.00
Use of Preventive Health Services in People With Serious Mental Illness: Consumer Perspectives on Barriers and Solutions PDF quantity
$ 40.00
×
Efficacy and Safety of Low-Dose Doxepin in Depressed Patients Suffering From Insomnia: A Retrospective, Naturalistic Case Series Analysis PDF
$ 40.00
Efficacy and Safety of Low-Dose Doxepin in Depressed Patients Suffering From Insomnia: A Retrospective, Naturalistic Case Series Analysis PDF quantity
$ 40.00
×
Remission Rates Following Electroconvulsive Therapy and Relation to Index Episode Duration in Patients With Psychotic Versus Nonpsychotic Late-Life Depression PDF
$ 40.00
Remission Rates Following Electroconvulsive Therapy and Relation to Index Episode Duration in Patients With Psychotic Versus Nonpsychotic Late-Life Depression PDF quantity
$ 40.00
×
Acute Effects of Parent Stimulant Medication Versus Behavioral Parent Training on Mothers' ADHD, Parenting Behavior, and At-Risk Children PDF
$ 40.00
Acute Effects of Parent Stimulant Medication Versus Behavioral Parent Training on Mothers' ADHD, Parenting Behavior, and At-Risk Children PDF quantity
$ 40.00
×
Psychotic Features in Patients With Major Depressive Disorder: A Report From the European Group for the Study of Resistant Depression PDF
$ 40.00
Psychotic Features in Patients With Major Depressive Disorder: A Report From the European Group for the Study of Resistant Depression PDF quantity
$ 40.00
×
The History and Current State of Antidepressant Clinical Trial Design: A Call to Action for Proof-of-Concept Studies PDF
$ 40.00
The History and Current State of Antidepressant Clinical Trial Design: A Call to Action for Proof-of-Concept Studies PDF quantity
$ 40.00
×
Prognostic Subgroups for Remission, Response, and Treatment Continuation in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Trial PDF
$ 40.00
Prognostic Subgroups for Remission, Response, and Treatment Continuation in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Trial PDF quantity
$ 40.00
×
Serotonin-System Polymorphisms (5-HTTLPR and -1438G/A) and Responses of Patients With Bulimic Syndromes to Multimodal Treatments PDF
$ 40.00
Serotonin-System Polymorphisms (5-HTTLPR and -1438G/A) and Responses of Patients With Bulimic Syndromes to Multimodal Treatments PDF quantity
$ 40.00
×
Longitudinal Trajectories of Psychotic-Like Experiences and Their Relationship to Emergent Mental Disorders Among Adolescents: A 3-Year Cohort Study PDF
$ 40.00
Longitudinal Trajectories of Psychotic-Like Experiences and Their Relationship to Emergent Mental Disorders Among Adolescents: A 3-Year Cohort Study PDF quantity
$ 40.00
×
A Meta-Analytic Review of Double-Blind, Placebo-Controlled Trials of Antidepressant Efficacy of Omega-3 Fatty Acids PDF
$ 40.00
A Meta-Analytic Review of Double-Blind, Placebo-Controlled Trials of Antidepressant Efficacy of Omega-3 Fatty Acids PDF quantity
$ 40.00
×
The Economic Burden of Schizophrenia in the United States in 2002 PDF
$ 40.00
The Economic Burden of Schizophrenia in the United States in 2002 PDF quantity
$ 40.00
×
Which Factors Predict Placebo Response in Anxiety Disorders and Major Depression? An Analysis of Placebo-Controlled Studies of Escitalopram PDF
$ 40.00
Which Factors Predict Placebo Response in Anxiety Disorders and Major Depression? An Analysis of Placebo-Controlled Studies of Escitalopram PDF quantity
$ 40.00
×
Observational Evidence for Buprenorphine's Impact on Posttraumatic Stress Symptoms in Veterans With Chronic Pain and Opioid Use Disorder PDF
$ 40.00
Observational Evidence for Buprenorphine's Impact on Posttraumatic Stress Symptoms in Veterans With Chronic Pain and Opioid Use Disorder PDF quantity
$ 40.00
×
Predictors of Sustained Response to Rivastigmine in Patients With Alzheimer's Disease: A Retrospective Analysis PDF
$ 40.00
Predictors of Sustained Response to Rivastigmine in Patients With Alzheimer's Disease: A Retrospective Analysis PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart